Fundz

Tagworks Pharmaceuticals Appoints Keith Orford as Chief Medical Officer

PRIVATEApr 22, 2025

Position

Chief Medical Officer

Company

Tagworks Pharmaceuticals

Keith Orford
keith.orford@tagworkspharma.com
NijmegenBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Tagworks Pharmaceuticals today announced the appointment of Keith Orford, MD, PhD, as Chief Medical Officer. This strategic addition to the leadership team is aimed at furthering Tagworks' innovative cancer drug development efforts.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Tagworks Pharmaceuticals, and when

A new leader at Tagworks Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tagworks Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tagworks Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tagworks Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tagworks Pharmaceuticals

Location

Nijmegen, Gelderland, Netherlands

About

Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted radionuclide therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tagworks Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Raffaella
Likely contact at this company
••••••••@••••••••

See Raffaella's verified email →

Ken
Likely contact at this company
••••••••@••••••••

See Ken's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tagworks Pharmaceuticals's next move

Learn about Strategic plan

Tagworks Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.